Patents by Inventor Hongli SHAO

Hongli SHAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Naphthalenesulfonamide compound, preparation method, and application
    Patent number: 11773057
    Abstract: Disclosed in the present invention are a naphthalenesulfonamide compound, a preparation method, and an application. The naphthalenesulfonamide compound provided by the present invention can interfere with Keap1-Nrf2 binding and activate Nrf2 to relieve inflammatory damage and improve an inflammatory microenvironment, has a potential anti-inflammatory activity, and can be used for preparing an anti-inflammatory drug for inflammatory damage of various inflammation-related diseases, including chronic obstructive pulmonary disease (COPD), Alzheimer's disease, Parkinson's disease, atherosclerosis, chronic kidney disease (CKD), diabetes, intestinal Inflammations, rheumatoid arthritis, etc.
    Type: Grant
    Filed: April 13, 2020
    Date of Patent: October 3, 2023
    Assignee: CHINA PHARMACEUTICAL UNIVERSITY
    Inventors: Qidong You, Zhengyu Jiang, Yuting Liu, Mengchen Lu, Hongli Shao, Jing Zhao, Xiaoli Xu, Xiaoke Guo, Lei Wang
  • NAPHTHALENESULFONAMIDE COMPOUND, PREPARATION METHOD, AND APPLICATION
    Publication number: 20220251035
    Abstract: Disclosed in the present invention are a naphthalenesulfonamide compound, a preparation method, and an application. The naphthalenesulfonamide compound provided by the present invention can interfere with Keap1-Nrf2 binding and activate Nrf2 to relieve inflammatory damage and improve an inflammatory microenvironment, has a potential anti-inflammatory activity, and can be used for preparing an anti-inflammatory drug for inflammatory damage of various inflammation-related diseases, including chronic obstructive pulmonary disease (COPD), Alzheimer's disease, Parkinson's disease, atherosclerosis, chronic kidney disease (CKD), diabetes, intestinal Inflammations, rheumatoid arthritis, etc.
    Type: Application
    Filed: April 13, 2020
    Publication date: August 11, 2022
    Applicant: CHINA PHARMACEUTICAL UNIVERSITY
    Inventors: Qidong YOU, Zhengyu JIANG, Yuting LIU, Mengchen LU, Hongli SHAO, Jing ZHAO, Xiaoli XU, Xiaoke GUO, Lei WANG